Jérémy Brunet et al.
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model
Journal of Virology 2024, vol. 98, issue 5
doi: 10.1128/jvi.01693-23